Works matching IS 02704137 AND DT 2024 AND VI 84 AND IP 5

Results: 9

Prostate‐specific membrane antigen (PSMA) glycoforms in prostate cancer patients seminal plasma.

Published in:

Prostate, 2024, v. 84, n. 5, p. 479, doi. 10.1002/pros.24666

By:

Mackay, Stephen;
Oduor, Ian O.;
Burch, Tanya C.;
Troyer, Dean A.;
Semmes, Oliver J.;
Nyalwidhe, Julius O.

Publication type:

Article

Fewer systematic prostate core biopsies in clinical stage T1c prostate cancer leads to biochemical recurrence after brachytherapy as monotherapy.

Published in:

Prostate, 2024, v. 84, n. 5, p. 502, doi. 10.1002/pros.24668

By:

Ozawa, Yu;
Nohara, Sunao;
Nakamura, Ken;
Hattori, Seiya;
Yagi, Yasuto;
Nishiyama, Toru;
Yorozu, Atsunori;
Monma, Tetsuo;
Saito, Shiro

Publication type:

Article

Distribution of neurovascular structures within the prostate gland and their relationship to complications after radical prostatectomy.

Published in:

Prostate, 2024, v. 84, n. 5, p. 491, doi. 10.1002/pros.24667

By:

Alanazi, Ghazi;
Alsubaie, Najah;
Nabi, Ghulam;
Gillingwater, Thomas H.;
Alashkham, Abduelmenem

Publication type:

Article

Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer.

Published in:

Prostate, 2024, v. 84, n. 5, p. 473, doi. 10.1002/pros.24665

By:

Pellegrino, Francesco;
Stabile, Armando;
Sorce, Gabriele;
Mazzone, Elio;
Cannoletta, Donato;
Cirulli, Giuseppe Ottone;
Quarta, Leonardo;
Leni, Riccardo;
Robesti, Daniele;
Brembilla, Giorgio;
Gandaglia, Giorgio;
De Cobelli, Francesco;
Montorsi, Francesco;
Briganti, Alberto

Publication type:

Article

Diagnosis and management of neuroendocrine prostate cancer.

Published in:

Prostate, 2024, v. 84, n. 5, p. 426, doi. 10.1002/pros.24664

By:

de Kouchkovsky, Ivan;
Chan, Emily;
Schloss, Charles;
Poehlein, Christian;
Aggarwal, Rahul

Publication type:

Article

Whole‐exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathways.

Published in:

Prostate, 2024, v. 84, n. 5, p. 460, doi. 10.1002/pros.24662

By:

White, Jason A.;
Kaninjing, Ernest T.;
Adeniji, Kayode A.;
Jibrin, Paul;
Obafunwa, John O.;
Ogo, Chidiebere N.;
Mohammed, Faruk;
Popoola, Ademola;
Fatiregun, Omolara A.;
Oluwole, Olabode P.;
Thorpe, Roland J.;
Karanam, Balasubramanyam;
Elhussin, Isra;
Ambs, Stefan;
Tang, Wei;
Davis, Melissa;
Polak, Paz;
Campbell, Moray J.;
Brignole, Kathryn R.;
Rotimi, Solomon O.

Publication type:

Article

Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5‐alpha reductase inhibitor resistance.

Published in:

Prostate, 2024, v. 84, n. 5, p. 441, doi. 10.1002/pros.24661

By:

Jin, Renjie;
Forbes, Connor M.;
Miller, Nicole L.;
Lafin, John;
Strand, Douglas W.;
Case, Thomas;
Cates, Justin M.;
Liu, Qi;
Ramirez‐Solano, Marisol;
Mohler, James L.;
Matusik, Robert J.

Publication type:

Article

Link between circadian rhythm and benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS).

Published in:

Prostate, 2024, v. 84, n. 5, p. 417, doi. 10.1002/pros.24656

By:

Cavanaugh, Dana;
Urbanucci, Alfonso;
Mohamed, Nihal E.;
Tewari, Ashutosh K.;
Figueiro, Mariana;
Kyprianou, Natasha

Publication type:

Article

Issue Information.

Published in:: Prostate, 2024, v. 84, n. 5, p. 415, doi. 10.1002/pros.24565
Publication type:: Article